Global Long-acting DPP-4 Inhibitor Drug Market Growth (Status and Outlook) 2026-2032
The global Long-acting DPP-4 Inhibitor Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Long-acting dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of drugs used to treat type 2 diabetes. They are characterized by a long half-life and extended duration of action, with some formulations allowing for once-weekly dosing and others even every two weeks.
United States market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-acting DPP-4 Inhibitor Drug players cover Merck & Co, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Long-acting DPP-4 Inhibitor Drug Industry Forecast? looks at past sales and reviews total world Long-acting DPP-4 Inhibitor Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting DPP-4 Inhibitor Drug sales for 2026 through 2032. With Long-acting DPP-4 Inhibitor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting DPP-4 Inhibitor Drug industry.
This Insight Report provides a comprehensive analysis of the global Long-acting DPP-4 Inhibitor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting DPP-4 Inhibitor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Long-acting DPP-4 Inhibitor Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting DPP-4 Inhibitor Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting DPP-4 Inhibitor Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting DPP-4 Inhibitor Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
Long-acting dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of drugs used to treat type 2 diabetes. They are characterized by a long half-life and extended duration of action, with some formulations allowing for once-weekly dosing and others even every two weeks.
United States market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-acting DPP-4 Inhibitor Drug players cover Merck & Co, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Long-acting DPP-4 Inhibitor Drug Industry Forecast? looks at past sales and reviews total world Long-acting DPP-4 Inhibitor Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting DPP-4 Inhibitor Drug sales for 2026 through 2032. With Long-acting DPP-4 Inhibitor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting DPP-4 Inhibitor Drug industry.
This Insight Report provides a comprehensive analysis of the global Long-acting DPP-4 Inhibitor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting DPP-4 Inhibitor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Long-acting DPP-4 Inhibitor Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting DPP-4 Inhibitor Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting DPP-4 Inhibitor Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting DPP-4 Inhibitor Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Weekly
- Biweekly
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co
- Takeda Pharmaceutical
- Furiex
- Beacon Pharma
- Kelun Pharmaceutical
- Haisco Pharmaceutical
- Easton Biopharmaceuticals
- Baiji Dichang Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting DPP-4 Inhibitor Drug Market Size (2021-2032)
2.1.2 Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-acting DPP-4 Inhibitor Drug by Country/Region (2021, 2025 & 2032)
2.2 Long-acting DPP-4 Inhibitor Drug Segment by Type
2.2.1 Weekly
2.2.2 Biweekly
2.2.3 Long-acting DPP-4 Inhibitor Drug Market Size by Type
2.2.3.1 Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
2.3 Long-acting DPP-4 Inhibitor Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Long-acting DPP-4 Inhibitor Drug Market Size by Application
2.3.4.1 Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
3 LONG-ACTING DPP-4 INHIBITOR DRUG MARKET SIZE BY PLAYER
3.1 Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Player
3.1.1 Global Long-acting DPP-4 Inhibitor Drug Revenue by Player (2021-2026)
3.1.2 Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Player (2021-2026)
3.2 Global Long-acting DPP-4 Inhibitor Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING DPP-4 INHIBITOR DRUG BY REGION
4.1 Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026)
4.2 Global Long-acting DPP-4 Inhibitor Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
4.4 APAC Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
4.5 Europe Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026)
5.2 Americas Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
5.3 Americas Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026)
6.2 APAC Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
6.3 APAC Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026)
7.2 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
7.3 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting DPP-4 Inhibitor Drug by Region (2021-2026)
8.2 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING DPP-4 INHIBITOR DRUG MARKET FORECAST
10.1 Global Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.1.1 Global Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.1.2 Americas Long-acting DPP-4 Inhibitor Drug Forecast
10.1.3 APAC Long-acting DPP-4 Inhibitor Drug Forecast
10.1.4 Europe Long-acting DPP-4 Inhibitor Drug Forecast
10.1.5 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Forecast
10.2 Americas Long-acting DPP-4 Inhibitor Drug Forecast by Country (2027-2032)
10.2.1 United States Market Long-acting DPP-4 Inhibitor Drug Forecast
10.2.2 Canada Market Long-acting DPP-4 Inhibitor Drug Forecast
10.2.3 Mexico Market Long-acting DPP-4 Inhibitor Drug Forecast
10.2.4 Brazil Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3 APAC Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.3.1 China Long-acting DPP-4 Inhibitor Drug Market Forecast
10.3.2 Japan Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.3 Korea Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.4 Southeast Asia Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.5 India Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.6 Australia Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4 Europe Long-acting DPP-4 Inhibitor Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.2 France Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.3 UK Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.4 Italy Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.5 Russia Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5.2 South Africa Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5.3 Israel Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5.4 Turkey Market Long-acting DPP-4 Inhibitor Drug Forecast
10.6 Global Long-acting DPP-4 Inhibitor Drug Forecast by Type (2027-2032)
10.7 Global Long-acting DPP-4 Inhibitor Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-acting DPP-4 Inhibitor Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck & Co
11.1.1 Merck & Co Company Information
11.1.2 Merck & Co Long-acting DPP-4 Inhibitor Drug Product Offered
11.1.3 Merck & Co Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Merck & Co Main Business Overview
11.1.5 Merck & Co Latest Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Information
11.2.2 Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.2.3 Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Takeda Pharmaceutical Main Business Overview
11.2.5 Takeda Pharmaceutical Latest Developments
11.3 Furiex
11.3.1 Furiex Company Information
11.3.2 Furiex Long-acting DPP-4 Inhibitor Drug Product Offered
11.3.3 Furiex Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Furiex Main Business Overview
11.3.5 Furiex Latest Developments
11.4 Beacon Pharma
11.4.1 Beacon Pharma Company Information
11.4.2 Beacon Pharma Long-acting DPP-4 Inhibitor Drug Product Offered
11.4.3 Beacon Pharma Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Beacon Pharma Main Business Overview
11.4.5 Beacon Pharma Latest Developments
11.5 Kelun Pharmaceutical
11.5.1 Kelun Pharmaceutical Company Information
11.5.2 Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.5.3 Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Kelun Pharmaceutical Main Business Overview
11.5.5 Kelun Pharmaceutical Latest Developments
11.6 Haisco Pharmaceutical
11.6.1 Haisco Pharmaceutical Company Information
11.6.2 Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.6.3 Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Haisco Pharmaceutical Main Business Overview
11.6.5 Haisco Pharmaceutical Latest Developments
11.7 Easton Biopharmaceuticals
11.7.1 Easton Biopharmaceuticals Company Information
11.7.2 Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Product Offered
11.7.3 Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Easton Biopharmaceuticals Main Business Overview
11.7.5 Easton Biopharmaceuticals Latest Developments
11.8 Baiji Dichang Pharmaceutical
11.8.1 Baiji Dichang Pharmaceutical Company Information
11.8.2 Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.8.3 Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Baiji Dichang Pharmaceutical Main Business Overview
11.8.5 Baiji Dichang Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting DPP-4 Inhibitor Drug Market Size (2021-2032)
2.1.2 Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-acting DPP-4 Inhibitor Drug by Country/Region (2021, 2025 & 2032)
2.2 Long-acting DPP-4 Inhibitor Drug Segment by Type
2.2.1 Weekly
2.2.2 Biweekly
2.2.3 Long-acting DPP-4 Inhibitor Drug Market Size by Type
2.2.3.1 Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
2.3 Long-acting DPP-4 Inhibitor Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Long-acting DPP-4 Inhibitor Drug Market Size by Application
2.3.4.1 Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
3 LONG-ACTING DPP-4 INHIBITOR DRUG MARKET SIZE BY PLAYER
3.1 Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Player
3.1.1 Global Long-acting DPP-4 Inhibitor Drug Revenue by Player (2021-2026)
3.1.2 Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Player (2021-2026)
3.2 Global Long-acting DPP-4 Inhibitor Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING DPP-4 INHIBITOR DRUG BY REGION
4.1 Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026)
4.2 Global Long-acting DPP-4 Inhibitor Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
4.4 APAC Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
4.5 Europe Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026)
5.2 Americas Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
5.3 Americas Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026)
6.2 APAC Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
6.3 APAC Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026)
7.2 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
7.3 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting DPP-4 Inhibitor Drug by Region (2021-2026)
8.2 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING DPP-4 INHIBITOR DRUG MARKET FORECAST
10.1 Global Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.1.1 Global Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.1.2 Americas Long-acting DPP-4 Inhibitor Drug Forecast
10.1.3 APAC Long-acting DPP-4 Inhibitor Drug Forecast
10.1.4 Europe Long-acting DPP-4 Inhibitor Drug Forecast
10.1.5 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Forecast
10.2 Americas Long-acting DPP-4 Inhibitor Drug Forecast by Country (2027-2032)
10.2.1 United States Market Long-acting DPP-4 Inhibitor Drug Forecast
10.2.2 Canada Market Long-acting DPP-4 Inhibitor Drug Forecast
10.2.3 Mexico Market Long-acting DPP-4 Inhibitor Drug Forecast
10.2.4 Brazil Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3 APAC Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.3.1 China Long-acting DPP-4 Inhibitor Drug Market Forecast
10.3.2 Japan Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.3 Korea Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.4 Southeast Asia Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.5 India Market Long-acting DPP-4 Inhibitor Drug Forecast
10.3.6 Australia Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4 Europe Long-acting DPP-4 Inhibitor Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.2 France Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.3 UK Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.4 Italy Market Long-acting DPP-4 Inhibitor Drug Forecast
10.4.5 Russia Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5.2 South Africa Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5.3 Israel Market Long-acting DPP-4 Inhibitor Drug Forecast
10.5.4 Turkey Market Long-acting DPP-4 Inhibitor Drug Forecast
10.6 Global Long-acting DPP-4 Inhibitor Drug Forecast by Type (2027-2032)
10.7 Global Long-acting DPP-4 Inhibitor Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-acting DPP-4 Inhibitor Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck & Co
11.1.1 Merck & Co Company Information
11.1.2 Merck & Co Long-acting DPP-4 Inhibitor Drug Product Offered
11.1.3 Merck & Co Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Merck & Co Main Business Overview
11.1.5 Merck & Co Latest Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Information
11.2.2 Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.2.3 Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Takeda Pharmaceutical Main Business Overview
11.2.5 Takeda Pharmaceutical Latest Developments
11.3 Furiex
11.3.1 Furiex Company Information
11.3.2 Furiex Long-acting DPP-4 Inhibitor Drug Product Offered
11.3.3 Furiex Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Furiex Main Business Overview
11.3.5 Furiex Latest Developments
11.4 Beacon Pharma
11.4.1 Beacon Pharma Company Information
11.4.2 Beacon Pharma Long-acting DPP-4 Inhibitor Drug Product Offered
11.4.3 Beacon Pharma Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Beacon Pharma Main Business Overview
11.4.5 Beacon Pharma Latest Developments
11.5 Kelun Pharmaceutical
11.5.1 Kelun Pharmaceutical Company Information
11.5.2 Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.5.3 Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Kelun Pharmaceutical Main Business Overview
11.5.5 Kelun Pharmaceutical Latest Developments
11.6 Haisco Pharmaceutical
11.6.1 Haisco Pharmaceutical Company Information
11.6.2 Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.6.3 Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Haisco Pharmaceutical Main Business Overview
11.6.5 Haisco Pharmaceutical Latest Developments
11.7 Easton Biopharmaceuticals
11.7.1 Easton Biopharmaceuticals Company Information
11.7.2 Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Product Offered
11.7.3 Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Easton Biopharmaceuticals Main Business Overview
11.7.5 Easton Biopharmaceuticals Latest Developments
11.8 Baiji Dichang Pharmaceutical
11.8.1 Baiji Dichang Pharmaceutical Company Information
11.8.2 Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
11.8.3 Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Baiji Dichang Pharmaceutical Main Business Overview
11.8.5 Baiji Dichang Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-acting DPP-4 Inhibitor Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Weekly
Table 4. Major Players of Biweekly
Table 5. Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Table 8. Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Long-acting DPP-4 Inhibitor Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Player (2021-2026)
Table 13. Long-acting DPP-4 Inhibitor Drug Key Players Head office and Products Offered
Table 14. Long-acting DPP-4 Inhibitor Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Long-acting DPP-4 Inhibitor Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Long-acting DPP-4 Inhibitor Drug
Table 39. Key Market Challenges & Risks of Long-acting DPP-4 Inhibitor Drug
Table 40. Key Industry Trends of Long-acting DPP-4 Inhibitor Drug
Table 41. Global Long-acting DPP-4 Inhibitor Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Long-acting DPP-4 Inhibitor Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Long-acting DPP-4 Inhibitor Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Merck & Co Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 46. Merck & Co Long-acting DPP-4 Inhibitor Drug Product Offered
Table 47. Merck & Co Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Merck & Co Main Business
Table 49. Merck & Co Latest Developments
Table 50. Takeda Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 51. Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 52. Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Takeda Pharmaceutical Main Business
Table 54. Takeda Pharmaceutical Latest Developments
Table 55. Furiex Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 56. Furiex Long-acting DPP-4 Inhibitor Drug Product Offered
Table 57. Furiex Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Furiex Main Business
Table 59. Furiex Latest Developments
Table 60. Beacon Pharma Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 61. Beacon Pharma Long-acting DPP-4 Inhibitor Drug Product Offered
Table 62. Beacon Pharma Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Beacon Pharma Main Business
Table 64. Beacon Pharma Latest Developments
Table 65. Kelun Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 66. Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 67. Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Kelun Pharmaceutical Main Business
Table 69. Kelun Pharmaceutical Latest Developments
Table 70. Haisco Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 71. Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 72. Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Haisco Pharmaceutical Main Business
Table 74. Haisco Pharmaceutical Latest Developments
Table 75. Easton Biopharmaceuticals Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 76. Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Product Offered
Table 77. Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Easton Biopharmaceuticals Main Business
Table 79. Easton Biopharmaceuticals Latest Developments
Table 80. Baiji Dichang Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 81. Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 82. Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Baiji Dichang Pharmaceutical Main Business
Table 84. Baiji Dichang Pharmaceutical Latest Developments
Table 1. Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-acting DPP-4 Inhibitor Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Weekly
Table 4. Major Players of Biweekly
Table 5. Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Table 8. Long-acting DPP-4 Inhibitor Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Long-acting DPP-4 Inhibitor Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Player (2021-2026)
Table 13. Long-acting DPP-4 Inhibitor Drug Key Players Head office and Products Offered
Table 14. Long-acting DPP-4 Inhibitor Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Long-acting DPP-4 Inhibitor Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Long-acting DPP-4 Inhibitor Drug
Table 39. Key Market Challenges & Risks of Long-acting DPP-4 Inhibitor Drug
Table 40. Key Industry Trends of Long-acting DPP-4 Inhibitor Drug
Table 41. Global Long-acting DPP-4 Inhibitor Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Long-acting DPP-4 Inhibitor Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Long-acting DPP-4 Inhibitor Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Merck & Co Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 46. Merck & Co Long-acting DPP-4 Inhibitor Drug Product Offered
Table 47. Merck & Co Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Merck & Co Main Business
Table 49. Merck & Co Latest Developments
Table 50. Takeda Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 51. Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 52. Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Takeda Pharmaceutical Main Business
Table 54. Takeda Pharmaceutical Latest Developments
Table 55. Furiex Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 56. Furiex Long-acting DPP-4 Inhibitor Drug Product Offered
Table 57. Furiex Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Furiex Main Business
Table 59. Furiex Latest Developments
Table 60. Beacon Pharma Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 61. Beacon Pharma Long-acting DPP-4 Inhibitor Drug Product Offered
Table 62. Beacon Pharma Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Beacon Pharma Main Business
Table 64. Beacon Pharma Latest Developments
Table 65. Kelun Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 66. Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 67. Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Kelun Pharmaceutical Main Business
Table 69. Kelun Pharmaceutical Latest Developments
Table 70. Haisco Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 71. Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 72. Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Haisco Pharmaceutical Main Business
Table 74. Haisco Pharmaceutical Latest Developments
Table 75. Easton Biopharmaceuticals Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 76. Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Product Offered
Table 77. Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Easton Biopharmaceuticals Main Business
Table 79. Easton Biopharmaceuticals Latest Developments
Table 80. Baiji Dichang Pharmaceutical Details, Company Type, Long-acting DPP-4 Inhibitor Drug Area Served and Its Competitors
Table 81. Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product Offered
Table 82. Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Baiji Dichang Pharmaceutical Main Business
Table 84. Baiji Dichang Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Long-acting DPP-4 Inhibitor Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-acting DPP-4 Inhibitor Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-acting DPP-4 Inhibitor Drug Sales Market Share by Country/Region (2025)
Figure 8. Long-acting DPP-4 Inhibitor Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type in 2025
Figure 10. Long-acting DPP-4 Inhibitor Drug in Hospital
Figure 11. Global Long-acting DPP-4 Inhibitor Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Long-acting DPP-4 Inhibitor Drug in Clinic
Figure 13. Global Long-acting DPP-4 Inhibitor Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Long-acting DPP-4 Inhibitor Drug in Others
Figure 15. Global Long-acting DPP-4 Inhibitor Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application in 2025
Figure 17. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Player in 2025
Figure 18. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Long-acting DPP-4 Inhibitor Drug Value Market Share by Country in 2025
Figure 24. United States Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region in 2025
Figure 29. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Country in 2025
Figure 38. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 61. China Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 65. India Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 68. France Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 1. Long-acting DPP-4 Inhibitor Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-acting DPP-4 Inhibitor Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-acting DPP-4 Inhibitor Drug Sales Market Share by Country/Region (2025)
Figure 8. Long-acting DPP-4 Inhibitor Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type in 2025
Figure 10. Long-acting DPP-4 Inhibitor Drug in Hospital
Figure 11. Global Long-acting DPP-4 Inhibitor Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Long-acting DPP-4 Inhibitor Drug in Clinic
Figure 13. Global Long-acting DPP-4 Inhibitor Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Long-acting DPP-4 Inhibitor Drug in Others
Figure 15. Global Long-acting DPP-4 Inhibitor Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application in 2025
Figure 17. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Player in 2025
Figure 18. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Long-acting DPP-4 Inhibitor Drug Value Market Share by Country in 2025
Figure 24. United States Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region in 2025
Figure 29. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Country in 2025
Figure 38. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Long-acting DPP-4 Inhibitor Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 61. China Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 65. India Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 68. France Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Long-acting DPP-4 Inhibitor Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Long-acting DPP-4 Inhibitor Drug Market Size 2027-2032 ($ millions)
